(HealthDay News) — For women treated for stage I endometrial cancer, telephone follow-up (TFU) is noninferior to hospital-based follow-up (HFU), according to a study published online April 7 in BJOG: An International Journal of Obstetrics and Gynaecology.

Kinta Beaver, Ph.D., from the University of Central Lancashire in the United Kingdom, and colleagues conducted a randomized, noninferiority trial involving 259 women treated for stage I endometrial cancer. Participants were randomized to receive traditional HFU or nurse-led TFU.

The researchers found that the groups had similar State Trait Anxiety Inventory scores after randomization, with an estimated between-group difference of 0.7 (95 percent confidence interval, −1.9 to 3.3, with the confidence interval above the noninferiority limit of −3.5, indicating non-inferiority). Reported satisfaction with information did not differ significantly between the groups (odds ratio, 0.9; 95 percent confidence interval, 0.4 to 2.1). The HFU group was more likely to report being kept waiting for their appointment and not needing any information; they were also less likely to report that the nurse knew about their specific case.

“The TFU provides an effective alternative to HFU for patients with stage I endometrial cancer, with no reported physical or psychological detriment,” the authors write. “Patient satisfaction with information was high, with similar levels between groups.”

Abstract
Full Text (subscription or payment may be required)